Association Between Dementia Development and COVID-19 Among Individuals Who Tested Negative for COVID-19 in South Korea: A Nationwide Cohort Study

Overview

Journal Am J Alzheimers Dis Other Demen

Publisher Sage Publications

Specialty Neurology

Date 2022 Jan 20

PMID 35050807

Authors

Namwoo Kim

Sungtaek Son

Saemina Kim

Jieun Lee

Yong Min Ahn

Dong Keon Yon

Bong-Jin Hahm

Affiliations

Soon will be listed here.

Abstract

We aim to assess whether the number of newly diagnosed dementia increases and whether comorbid psychiatric symptoms of patients with dementia worsen, in people who were tested for COVID-19. We used electronic medical records from a nationwide cohort consisting of people who tested positive (positive group), tested negative (negative group), and those who did not receive the test (control group) for COVID-19. For people with neither a history of dementia nor mild cognitive disorder (MCI), the negative group was more likely to develop dementia than the control group, and less likely to develop MCI than the positive group. For people who already had dementia, the negative group was more likely to develop comorbid psychiatric disorders than the control group, but less likely than the positive group. These findings suggest the necessity of managing mental health not only for patients with COVID-19 but also for people who tested negative for COVID-19.

Citing Articles

The Impact of COVID-19 on Psychiatric Health in the Korean Population.

Wang S, Kim S, Choi W, Lim H, Woo Y, Pae C Clin Psychopharmacol Neurosci. 2023; 21(3):410-418.

PMID: 37424410 PMC: 10335912. DOI: 10.9758/cpn.23.1083.

The viral hypothesis in Alzheimer's disease: SARS-CoV-2 on the cusp.

Liu N, Jiang X, Li H Front Aging Neurosci. 2023; 15:1129640.

PMID: 37009449 PMC: 10050697. DOI: 10.3389/fnagi.2023.1129640.

Positive Effect of Cognitive Training in Older Adults with Different Genotypes and COVID-19 History: A 1-Year Follow-Up Cohort Study.

Zorkina Y, Syunyakov T, Abramova O, Andryushchenko A, Andreuyk D, Abbazova E Diagnostics (Basel). 2022; 12(10).

PMID: 36292001 PMC: 9600912. DOI: 10.3390/diagnostics12102312.

References

Wang Q, Davis P, Gurney M, Xu R . COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021; 17(8):1297-1306. PMC: 8014535. DOI: 10.1002/alz.12296. View

Livingston G, Rostamipour H, Gallagher P, Kalafatis C, Shastri A, Huzzey L . Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study. Lancet Psychiatry. 2020; 7(12):1054-1063. PMC: 7535621. DOI: 10.1016/S2215-0366(20)30434-X. View

Pinna P, Grewal P, Hall J, Tavarez T, Dafer R, Garg R . Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J Neurol Sci. 2020; 415:116969. PMC: 7832569. DOI: 10.1016/j.jns.2020.116969. View

Goodman-Casanova J, Dura-Perez E, Guzman-Parra J, Cuesta-Vargas A, Mayoral-Cleries F . Telehealth Home Support During COVID-19 Confinement for Community-Dwelling Older Adults With Mild Cognitive Impairment or Mild Dementia: Survey Study. J Med Internet Res. 2020; 22(5):e19434. PMC: 7247465. DOI: 10.2196/19434. View

Edelman L, McConnell E, Kennerly S, Alderden J, Horn S, Yap T . Mitigating the Effects of a Pandemic: Facilitating Improved Nursing Home Care Delivery Through Technology. JMIR Aging. 2020; 3(1):e20110. PMC: 7252197. DOI: 10.2196/20110. View

Ousset P, Vellas B . Viewpoint: Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer's Disease Center Facing the Covid-19 Crisis. J Prev Alzheimers Dis. 2020; 7(3):197-198. PMC: 7147199. DOI: 10.14283/jpad.2020.17. View

Canevelli M, Bruno G, Cesari M . Providing Simultaneous COVID-19-sensitive and Dementia-Sensitive Care as We Transition from Crisis Care to Ongoing Care. J Am Med Dir Assoc. 2020; 21(7):968-969. PMC: 7241363. DOI: 10.1016/j.jamda.2020.05.025. View

Giebel C, Lord K, Cooper C, Shenton J, Cannon J, Pulford D . A UK survey of COVID-19 related social support closures and their effects on older people, people with dementia, and carers. Int J Geriatr Psychiatry. 2020; 36(3):393-402. PMC: 7536967. DOI: 10.1002/gps.5434. View

Kim L, Kim J, Kim S . A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health. 2014; 36:e2014008. PMC: 4151963. DOI: 10.4178/epih/e2014008. View

10.

Kennedy M, Helfand B, Gou R, Gartaganis S, Webb M, Moccia J . Delirium in Older Patients With COVID-19 Presenting to the Emergency Department. JAMA Netw Open. 2020; 3(11):e2029540. PMC: 7677760. DOI: 10.1001/jamanetworkopen.2020.29540. View

11.

Kim N, Cho S, Kim H, Kim S, Lee H, Park C . Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea. PLoS One. 2019; 14(8):e0221552. PMC: 6707549. DOI: 10.1371/journal.pone.0221552. View

12.

Padala S, Jendro A, Orr L . Facetime to reduce behavioral problems in a nursing home resident with Alzheimer's dementia during COVID-19. Psychiatry Res. 2020; 288:113028. PMC: 7177115. DOI: 10.1016/j.psychres.2020.113028. View

13.

Azarpazhooh M, Amiri A, Morovatdar N, Steinwender S, Rezaei Ardani A, Yassi N . Correlations between COVID-19 and burden of dementia: An ecological study and review of literature. J Neurol Sci. 2020; 416:117013. PMC: 7334961. DOI: 10.1016/j.jns.2020.117013. View

14.

Nalleballe K, Onteddu S, Sharma R, Dandu V, Brown A, Jasti M . Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020; 88:71-74. PMC: 7297688. DOI: 10.1016/j.bbi.2020.06.020. View

15.

Gerritsen D, Oude Voshaar R . The effects of the COVID-19 virus on mental healthcare for older people in The Netherlands. Int Psychogeriatr. 2020; 32(11):1353-1356. PMC: 7300185. DOI: 10.1017/S1041610220001040. View

16.

Yang H, Liang X, Hou H, Xu J, Shi L, Wang Y . The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates. J Infect. 2021; 82(5):e6-e10. PMC: 7879026. DOI: 10.1016/j.jinf.2021.02.013. View

17.

Borelli W, Augustin M, de Oliveira P, Reggiani L, Bandeira-de-Mello R, Schumacher-Schuh A . Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic. J Alzheimers Dis. 2021; 80(4):1705-1712. DOI: 10.3233/JAD-201513. View

18.

Taquet M, Luciano S, Geddes J, Harrison P . Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020; 8(2):130-140. PMC: 7820108. DOI: 10.1016/S2215-0366(20)30462-4. View

19.

Varatharaj A, Thomas N, Ellul M, Davies N, Pollak T, Tenorio E . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020; 7(10):875-882. PMC: 7316461. DOI: 10.1016/S2215-0366(20)30287-X. View

20.

Lara B, Carnes A, Dakterzada F, Benitez I, Pinol-Ripoll G . Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown. Eur J Neurol. 2020; 27(9):1744-1747. PMC: 7283827. DOI: 10.1111/ene.14339. View